{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:52:28Z","timestamp":1790416348098,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.drugalcdep.2014.10.027","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T16:10:49Z","timestamp":1416240649000},"page":"30-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":165,"special_numbering":"C","title":["Methamphetamine\/amphetamine abuse and risk of Parkinson's disease in Utah: A population-based assessment"],"prefix":"10.1016","volume":"146","author":[{"given":"Karen","family":"Curtin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette E.","family":"Fleckenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6784-9568","authenticated-orcid":false,"given":"Reid J.","family":"Robison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5379-0726","authenticated-orcid":false,"given":"Michael J.","family":"Crookston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen R.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/7854_2010_93","article-title":"Females are more vulnerable to drug abuse than males: evidence from preclinical studies and the role of ovarian hormones","volume":"8","author":"Anker","year":"2011","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/1471-244X-12-221","article-title":"Amphetamine-induced psychosis\u2014a separate diagnostic entity or primary psychosis triggered in the vulnerable?","volume":"12","author":"Bramness","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0306-4603(03)00082-0","article-title":"Methamphetamine use behaviors and gender differences","volume":"29","author":"Brecht","year":"2004","journal-title":"Addict Behav."},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0015","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1038\/sj.npp.1300859","article-title":"Do preclinical findings of methamphetamine-induced motor abnormalities translate to an observable clinical phenotype?","volume":"30","author":"Caligiuri","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.drugalcdep.2011.06.013","article-title":"Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs","volume":"120","author":"Callaghan","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0025","unstructured":"Centers for Disease Control and Prevention, 2011. High School Youth Risk Behavior Survey, Utah. Available from \u3008http:\/\/apps.nccd.cdc.gov\/youthonline\u3009. (accessed 23.01.14.)."},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0030","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/ijc.28266","article-title":"Familial risk of childhood cancer and tumors in the Li-Fraumeni spectrum in the Utah Population Database: implications for genetic evaluation in pediatric practice","volume":"133","author":"Curtin","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0195","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(11)61138-0","article-title":"Extent of illicit drug use and dependence, and their contribution to the global burden of disease","volume":"379","author":"Degenhardt","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0035","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0040","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0045","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","article-title":"New insights into the mechanism of action of amphetamines","volume":"47","author":"Fleckenstein","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0050","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.neuro.2006.03.015","article-title":"Amphetamine exposure is elevated in Parkinson's disease","volume":"27","author":"Garwood","year":"2006","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0055","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/archpsyc.61.11.1107","article-title":"Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions","volume":"61","author":"Grant","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0060","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.psc.2010.01.004","article-title":"Substance abuse in women","volume":"33","author":"Greenfield","year":"2010","journal-title":"Psychiatr. Clin. North Am."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2014.10.027_bib0065","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/j.neuropharm.2004.06.004","article-title":"The methamphetamine experience: a NIDA partnership","volume":"47","author":"Hanson","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0070","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1503\/cmaj.071675","article-title":"Pharmacologic mechanisms of crystal meth","volume":"178","author":"Kish","year":"2008","journal-title":"Can. Med. Assoc. J."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2014.10.027_bib0075","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/j.legalmed.2009.01.003","article-title":"Detection of methamphetamine neurotoxicity in forensic autopsy cases","volume":"11","author":"Kitamura","year":"2009","journal-title":"Leg. Med. (Tokyo)"},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0080","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000104096","article-title":"ICD-9 CM code 333.1 as an identifier of patients with essential tremor: a study of the positive predictive value of this code","volume":"28","author":"Louis","year":"2007","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0085","unstructured":"National Institutes of Health, 2004. National Institute of Neurological Disorders and Stroke (NINDS). Parkinson's Disease Backgrounder (http:\/\/www.ninds.nih.gov\/disorders\/parkinsons_disease\/parkinsons_disease_backgrounder.htm) (accessed 25.01.14)."},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0090","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/mds.21299","article-title":"Accuracy of Medicare claims data in identifying Parkinsonism cases: comparison with the Medicare current beneficiary survey","volume":"22","author":"Noyes","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0095","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00213-012-2727-8","article-title":"Sex differences in escalation of methamphetamine self-administration: cognitive and motivational consequences in rats","volume":"223","author":"Reichel","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0100","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00213-003-1670-0","article-title":"Sex differences in the acquisition of IV methamphetamine self-administration and subsequent maintenance under a progressive ratio schedule in rats","volume":"172","author":"Roth","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0105","first-page":"CD003026","article-title":"Treatment for amphetamine psychosis","volume":"4","author":"Srisurapanont","year":"2001","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0110","unstructured":"Substance Abuse and Mental Health Services Administration, 2006. Office of Applied Studies. The National Survey on Drug Use and Health (NSDUH) Report, State Estimates of Past Year Methamphetamine Use. \u3008http:\/\/www.samhsa.gov\/data\/2k6\/stateMeth\/StateMeth.pdf\u3009 (accessed 01.23.14)."},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0115","unstructured":"Substance Abuse and Mental Health Services Administration, 2011. Office of Applied Studies. Drug Abuse Warning Network, 2008. National Estimates of Drug-Related Emergency Department Visits, Rockville, MD."},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0120","unstructured":"Substance Abuse and Mental Health Services Administration, 2013. Office of Applied Studies. Results from the 2012 National Survey on Drug Use and Health (NSDUH): Summary of National Findings. HHS Publication no. (SMA) 13\u20134795."},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.drugalcdep.2012.09.015","article-title":"Decreased frontal lobe phosphocreatine levels in methamphetamine users","volume":"129","author":"Sung","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0130","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/mds.20479","article-title":"Identifying and distinguishing cases of parkinsonism and Parkinson's disease using ICD-9 CM codes and pharmacy data","volume":"20","author":"Swarztrauber","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mds.22283","article-title":"Optimizing algorithms to identify Parkinson's disease cases within an administrative database","volume":"24","author":"Szumski","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0140","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.parkreldis.2004.03.001","article-title":"Movement disorders and AIDS: a review","volume":"10","author":"Tse","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0145","unstructured":"Utah Department of Human Services, 2012. Division of Substance Abuse and Mental Health. Annual Report, 2012. \u3008http:\/\/www.dsamh.utah.gov\/docs\/Annual%20report%202012.pdf\u3009 (accessed 23.01.14)."},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0150","unstructured":"Utah Governor's Office of Planning and Budget, 2012. Census Brief: Race and Ethnicity in Utah (2010). Salt Lake City, Utah."},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0155","unstructured":"Utah Population Database, 2014. Huntsman Cancer Institute at the University of Utah. Table of Records Available. \u3008http:\/\/healthcare.utah.edu\/huntsmancancerinstitute\/research\/updb\/data\/\u3009 (accessed 25.01.14)."},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0160","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1176\/appi.ajp.158.3.377","article-title":"Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers","volume":"158","author":"Volkow","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/00952990802326280","article-title":"The impact of cigarette smoking on stimulant addiction","volume":"35","author":"Weinberger","year":"2009","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0170","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/mds.21353","article-title":"Identifying incident cases of parkinsonism among veterans using a tertiary medical center","volume":"22","author":"White","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0175","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.parkreldis.2012.09.014","article-title":"Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson's Disease in the United States","volume":"19","author":"Willis","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.drugalcdep.2014.10.027_bib0180","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nm0696-699","article-title":"Striatal dopamine nerve terminal markers in human, chronic methamphetamine users","volume":"2","author":"Wilson","year":"1996","journal-title":"Nat. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2014.10.027_bib0185","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s10654-011-9581-6","article-title":"Epidemiology and etiology of Parkinson's disease: a review of the evidence","volume":"26","author":"Wirdefeldt","year":"2011","journal-title":"Eur. J. Epidemiol."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614018948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614018948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T14:26:46Z","timestamp":1538058406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871614018948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":39,"alternative-id":["S0376871614018948"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.10.027","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methamphetamine\/amphetamine abuse and risk of Parkinson's disease in Utah: A population-based assessment","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}